Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
February 13, 2020
Join us at ENDO 2020, the most valued and well attended endocrinology meeting in the world. Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology. Enjoy time connecting with peers and colleagues, exchanging ideas and information, and gaining insights from the latest trends and advancements in hormone health.
February 29, 2020
We are excited to continue working with you in 2020 to unite, lead, and grow the endocrine community.
January 28, 2020
We know that clinicians and their patients have questions about endocrine-disrupting chemicals (EDCs). Compelling scientific evidence in recent decades has established strong links between chemical exposures and endocrine diseases, and patients may want to know about the evidence relating EDCs to specific diseases, or how they can control their exposures and reduce risks for themselves and their families.
February 03, 2020
The Endocrine Society’s Clinical Practice Guideline (CPG) app can help you meet Medicare payment reporting requirements
February 14, 2020
This week we provide a review of the President's proposed budget for FY 2021, an update on the latest drug pricing legislation, and the transgender health bills at the state level.
Need more info?
Learn more about the advantages of membership
February 18, 2020
The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture.
February 10, 2020
The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session.
February 05, 2020
The Endocrine Society has announced the departure of CEO Barbara Byrd Keenan, FASAE, CAE, effective February 5, 2020. Keenan had served in the role since 2014.
